Omega Therapeutics (OMGA) to Release Quarterly Earnings on Thursday

Omega Therapeutics (NASDAQ:OMGA) is anticipated to release its earnings data before the market opens on Thursday, March 27th. Analysts expect Omega Therapeutics to post earnings of ($0.28) per share for the quarter.

Omega Therapeutics Trading Down 21.8 %

NASDAQ OMGA opened at $0.13 on Thursday. Omega Therapeutics has a 12 month low of $0.10 and a 12 month high of $3.77. The company has a 50-day moving average of $0.29 and a 200-day moving average of $0.79. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.61 and a quick ratio of 1.61. The company has a market cap of $6.92 million, a P/E ratio of -0.09 and a beta of 1.65.

Omega Therapeutics Company Profile

Omega Therapeutics, Inc operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury.